284 related articles for article (PubMed ID: 11810583)
21. Activity of BMS-284756, a novel des-fluoro(6) quinolone, against Staphylococcus aureus, including contributions of mutations to quinolone resistance.
Low DE; Muller M; Duncan CL; Willey BM; de Azavedo JC; McGeer A; Kreiswirth BN; Pong-Porter S; Bast DJ
Antimicrob Agents Chemother; 2002 Apr; 46(4):1119-21. PubMed ID: 11897603
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of plasmid-mediated quinolone resistance and mutations in the gyrase and topoisomerase IV genes in Salmonella isolated from 12 tertiary-care hospitals in Korea.
Jeong HS; Kim JA; Shin JH; Chang CL; Jeong J; Cho JH; Kim MN; Kim S; Kim YR; Lee CH; Lee K; Lee MA; Lee WG; Shin JH; Lee JN
Microb Drug Resist; 2011 Dec; 17(4):551-7. PubMed ID: 21830947
[TBL] [Abstract][Full Text] [Related]
23. [Study on the DNA gyrA gene mutation with resistance to fluoroquinolones in Staphylococcus aureus isolated from patients].
Fang Z; Song X; Liu X
Hua Xi Yi Ke Da Xue Xue Bao; 2000 Mar; 31(1):24-6. PubMed ID: 12501604
[TBL] [Abstract][Full Text] [Related]
24. Efflux pump-mediated quinolone resistance in Staphylococcus aureus strains wild type for gyrA, gyrB, grlA, and norA.
Muñoz-Bellido JL; Alonzo Manzanares M; Martínez Andrés JA; Guttiérrez Zufiaurre MN; Ortiz G; Segovia Hernández M; García-Rodríguez JA
Antimicrob Agents Chemother; 1999 Feb; 43(2):354-6. PubMed ID: 9925531
[TBL] [Abstract][Full Text] [Related]
25. Mutations in topoisomerase IV and DNA gyrase of Staphylococcus aureus: novel pleiotropic effects on quinolone and coumarin activity.
Fournier B; Hooper DC
Antimicrob Agents Chemother; 1998 Jan; 42(1):121-8. PubMed ID: 9449271
[TBL] [Abstract][Full Text] [Related]
26. Quinolone resistance mutations in Streptococcus pneumoniae GyrA and ParC proteins: mechanistic insights into quinolone action from enzymatic analysis, intracellular levels, and phenotypes of wild-type and mutant proteins.
Pan XS; Yague G; Fisher LM
Antimicrob Agents Chemother; 2001 Nov; 45(11):3140-7. PubMed ID: 11600369
[TBL] [Abstract][Full Text] [Related]
27. Enhancement of fluoroquinolone activity by C-8 halogen and methoxy moieties: action against a gyrase resistance mutant of Mycobacterium smegmatis and a gyrase-topoisomerase IV double mutant of Staphylococcus aureus.
Lu T; Zhao X; Li X; Drlica-Wagner A; Wang JY; Domagala J; Drlica K
Antimicrob Agents Chemother; 2001 Oct; 45(10):2703-9. PubMed ID: 11557458
[TBL] [Abstract][Full Text] [Related]
28. Topoisomerase targeting with and resistance to gemifloxacin in Staphylococcus aureus.
Ince D; Zhang X; Silver LC; Hooper DC
Antimicrob Agents Chemother; 2003 Jan; 47(1):274-82. PubMed ID: 12499202
[TBL] [Abstract][Full Text] [Related]
29. Fluoroquinolone resistance linked to both gyrA and parC mutations in the quinolone resistance-determining region of Shigella dysenteriae type 1.
Talukder KA; Khajanchi BK; Islam MA; Islam Z; Dutta DK; Rahman M; Watanabe H; Nair GB; Sack DA
Curr Microbiol; 2006 Feb; 52(2):108-11. PubMed ID: 16450072
[TBL] [Abstract][Full Text] [Related]
30. Role of the extended alpha4 domain of Staphylococcus aureus gyrase A protein in determining low sensitivity to quinolones.
Strahilevitz J; Robicsek A; Hooper DC
Antimicrob Agents Chemother; 2006 Feb; 50(2):600-6. PubMed ID: 16436716
[TBL] [Abstract][Full Text] [Related]
31. An unusually high level of quinolone resistance associated with type II topoisomerase mutations in quinolone resistance-determining regions of Aeromonas caviae isolated from diarrhoeal patients.
Sinha S; Chattopadhyay S; Bhattacharya SK; Nair GB; Ramamurthy T
Res Microbiol; 2004 Dec; 155(10):827-9. PubMed ID: 15567276
[TBL] [Abstract][Full Text] [Related]
32. Reduction of the fitness burden of quinolone resistance in Pseudomonas aeruginosa.
Kugelberg E; Löfmark S; Wretlind B; Andersson DI
J Antimicrob Chemother; 2005 Jan; 55(1):22-30. PubMed ID: 15574475
[TBL] [Abstract][Full Text] [Related]
33. Prevalence and mechanisms of quinolone resistance among selected nontyphoid Salmonella isolated from food animals and humans in Korea.
Tamang MD; Nam HM; Kim A; Lee HS; Kim TS; Kim MJ; Jang GC; Jung SC; Lim SK
Foodborne Pathog Dis; 2011 Nov; 8(11):1199-206. PubMed ID: 21877929
[TBL] [Abstract][Full Text] [Related]
34. Topoisomerase mutations that are associated with high-level resistance to earlier fluoroquinolones in Staphylococcus aureus have less effect on the antibacterial activity of besifloxacin.
Sanfilippo CM; Hesje CK; Haas W; Morris TW
Chemotherapy; 2011; 57(5):363-71. PubMed ID: 21996946
[TBL] [Abstract][Full Text] [Related]
35. DNA gyrase and topoisomerase IV mutations in an in vitro fluoroquinolone-resistant Coxiella burnetii strain.
Vranakis I; Sandalakis V; Chochlakis D; Tselentis Y; Psaroulaki A
Microb Drug Resist; 2010 Jun; 16(2):111-7. PubMed ID: 20438350
[TBL] [Abstract][Full Text] [Related]
36. DX-619, a novel des-fluoro(6) quinolone manifesting low frequency of selection of resistant Staphylococcus aureus mutants: quinolone resistance beyond modification of type II topoisomerases.
Strahilevitz J; Truong-Bolduc QC; Hooper DC
Antimicrob Agents Chemother; 2005 Dec; 49(12):5051-7. PubMed ID: 16304172
[TBL] [Abstract][Full Text] [Related]
37. Determination of the primary target of a quinolone drug and the effect of quinolone resistance-conferring mutations by measuring quinolone sensitivity based on its mode of action.
Pfeiffer ES; Hiasa H
Antimicrob Agents Chemother; 2007 Sep; 51(9):3410-2. PubMed ID: 17606687
[TBL] [Abstract][Full Text] [Related]
38. Accumulation of mutations in DNA gyrase and topoisomerase IV genes contributes to fluoroquinolone resistance in Vibrio cholerae O139 strains.
Zhou Y; Yu L; Li J; Zhang L; Tong Y; Kan B
Int J Antimicrob Agents; 2013 Jul; 42(1):72-5. PubMed ID: 23643392
[TBL] [Abstract][Full Text] [Related]
39. Fluoroquinolone resistance and gyrA and parC mutations of Escherichia coli isolated from chicken.
Lee YJ; Cho JK; Kim KS; Tak RB; Kim AR; Kim JW; Im SK; Kim BH
J Microbiol; 2005 Oct; 43(5):391-7. PubMed ID: 16273029
[TBL] [Abstract][Full Text] [Related]
40. Genetic analyses of mutations contributing to fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
Weigel LM; Anderson GJ; Facklam RR; Tenover FC
Antimicrob Agents Chemother; 2001 Dec; 45(12):3517-23. PubMed ID: 11709333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
